Skip to content
★ Sign in to follow
RS
Total declarations
13
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€1.8M

Latest filing published 12 Nov 2019 for Pacira BioSciences, Inc., €144k.

Filing timeline

BuySale
Richard Scranton

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Richard Scranton: trading record in brief

Richard Scranton discloses dealings in Pacira BioSciences, Inc. to SEC (Form 4). Between 14 June 2017 and 8 November 2019, the trades on record add up to 13 filings.

Sales make up the whole of the open-market record (6 sales, €1.8M). Other entries cover 3 share grants and 4 option exercises. So far in 2019, the count stands at no purchases and 5 sales.

The newest entry dates from 12 November 2019: an option exercise of €144k, in Pacira BioSciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Richard Scranton

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total

13 of 13 declarations